Saftrax SB 250mg/125mg Injection
Marketer
Pluzine Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Saftrax SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be under a physician's guidance; strict adherence to the prescribed schedule is crucial for complete treatment, even with symptom improvement. Premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are recommended for optimal recovery. Monitoring via laboratory tests may be employed to assess treatment effectiveness.
Primary Ingredients of Saftrax SB 250mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Saftrax SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Saftrax SB 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Saftrax SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Saftrax SB 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Saftrax SB 250mg/125mg Injection works:
The injectable formulation Saftrax SB (250mg/125mg) unites Ceftriaxone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Saftrax SB 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Saftrax SB, containing 250mg/125mg, is usually deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful consequences to fetal development; nonetheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Saftrax SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Saftrax SB 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Saftrax SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation Saftrax SB 250mg/125mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Saftrax SB 250mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Saftrax SB 250mg/125mg Injection :
Omitting a scheduled dose of Saftrax SB 250mg/125mg Injection warrants immediate physician consultation.
Facts to Know About Saftrax SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently